Synthesis of diiodo(p-cymene)ruthenium(II) dimer (compound 4) The diiodo(p-cymene)ruthenium(II) dimer was synthetized using a similar procedure as previously reported 12
Dissolving microneedles for transdermal drug delivery: advances and challenges
In particular, the mitochondrial SOD (MnSOD/SOD2) converts .O 2 . into H 2 O 2 , which is less reactive than .O 2 . and so can readily be used for cellular signalling
doi: 10.1016/J.MCE.2013.03.018 142 Estrogens, male Reproduction and Beyond
Exclusion criteria: (1) Patients with abnormal coagulation function [limits: prothrombin time (PT) between 1014 seconds, activated partial thromboplastin time (APTT) between 2540 seconds, and fibrinogen (Fib) levels between 2.04.0 g/L] and immunodeficiency [either primary immunodeficiency (congenital or hereditary conditions leading to impaired immune responses) or secondary immunodeficiency (conditions acquired through HIV infection, chronic immunosuppressive therapy, or severe malnutrition)]
If metabolized too quickly drugs may be broken down and eliminated before they can take effect
